References
- 1. P. D. Darbre, Endocrine Disruption and Human Health, Elsevier Science, Amsterdam 2015, pp. 4–23, 28–43.
- 2. World Health Organization and United Nations Environment Programme, State of the Science of Endocrine Disrupting Chemicals – 2012, An assessment of the state of the science of endocrine disruptors prepared by a group of experts for the United Nations Environment Programme and World Health Organization, Inter-Organization Programme For the Sound Management of Chemicals, (Eds. Å. Bergman, J. J. Heindel, S. Jobling, K. A. Kidd and R. T. Zoeller), WHO Library Cataloguingin-Publication Data, Geneva 2013; https://www.who.int/ceh/publications/endocrine/en/; last access date December 19, 2019
- 3. L. N. Vandenberg, T. Colborn, T. B. Hayes, J. J. Heindel, D. R. Jacobs, Jr., D.-H. Lee, T. Shioda, A. M. Soto, F. S. vom Saal, W. V. Welshons, R. T. Zoeller and J. P. Myers, Hormones and endocrine-disrupting chemicals: Low dose effects and nonmonotonic dose responses, Endocr. Rev.33 (2012) 378–455; https://doi.org/10.1210/er.2011-1050
- 4. A. Myridakis, E. Fthenou, E. Balaska, M. Vakinti, M. Kogevinas and E. G. Stephanou, Phthalate esters, parabens and bisphenol-A exposure among mothers and their children in Greece (Rhea cohort), Environ. Int.83 (2015) 1–10; https://doi.org/10.1016/j.envint.2015.05.014
- 5. Y. Guo and K. Kannan, A survey of phthalates and parabens in personal care products from the United States and its implications for human exposure, Environ. Sci. Technol.47 (2013) 14442–14449; https://doi.org/10.1021/es4042034
- 6. American Council on Science and Health, Fear of Parabens Compromises Safety of Certain Cosmetic Products, ACSH, New York, August 2014; https://www.acsh.org/news/2014/08/26/fear-parabens-compromises-safety-certain-cosmetic-products; last access date December 19, 2019.
- 7. McGill University, Office for Science and Society, Separating Sense from Nonsense, J. Schwarcz, Paraben phobia is unjustified, Pseudoscience, March 20, 2017; https://www.mcgill.ca/oss/article/cancer-controversial-science-cosmetics-health-news-quackery-toxicity/joe-schwarczs-right-chemistry-paraben-phobia-unjustified; last access date December 19, 2019.
- 8. P. J. Sheskey, W. G. Cook and C. G. Cable, Handbook of Pharmaceutical Excipients, 8th ed., Pharmaceutical Press, London, and American Pharmacists Association, Washington D.C. 2017, pp. 130–133, 379–382, 604–608, 803–806.
- 9. C. G. Abrantes, D. Duarte and C. P. Reis, An overview of pharmaceutical excipients: Safe or not safe?, J. Pharm. Sci.105 (2016) 2019–2026; https://doi.org/10.1016/j.xphs.2016.03.019
- 10. M. G. Soni, I. G. Carabin and G. A. Burdock, Safety assessment of esters of p-hydroxybenzoic acid (parabens), Food Chem. Toxicol.43 (2005) 985–1015; https://doi.org/10.1016/j.fct.2005.01.020
- 11. C. Liao, F. Liu and K. Kannan, Occurrence of and dietary exposure to parabens in foodstuffs from the United States, Environ. Sci. Technol. 47 (2013) 3918–3925; https://doi.org/10.1021/es400724s
- 12. P. D. Darbre, A. Aljarrah, W. R. Miller, N. G. Coldham, M. J. Sauer and G. S. Pope, Concentrations of parabens in human breast tumours, J. Appl. Toxicol.24 (2004) 5–13; https://doi.org/10.1002/jat.958
- 13. N. Raza, K.-H. Kim, M. Abdullah, W. Raza and R. J. C. Brown, Recent developments in analytical quantitation approaches for parabens in human-associated sample, Trends Anal. Chem. 98 (2018) 161–173; https://doi.org/10.1016/j.trac.2017.11.009
- 14. M. Fisher, S. MacPherson, J. M. Braun, R. Hauser, M. Walker, M. Feeley, R. Mallick, R. Bérubé and T. E. Arbuckle, Paraben concentrations in maternal urine and breast milk and its association with personal care product use, Environ. Sci. Technol.51 (2017) 4009–4017; https://doi.org/10.1021/acs.est.6b04302
- 15. S. Shekhar, S. Sood, S. Showkat, C. Lite, A. Chandrasekhar, M. Vairamani, S. Barathi and W. Santosh, Detection of phenolic endocrine disrupting chemicals (EDCs) from maternal blood plasma and amniotic fluid in Indian population, Gen. Comp. Endocr. 241 (2017) 100–107; https://doi.org/10.1016/j.ygcen.2016.05.025
- 16. E. V. S Hessel, P. E. Boon, S.P. den Braver-Sewradj, J. A. J. Meesters, M. Weda and W. Brand, Review on butylparaben: exposure, toxicity and risk assessment – With a focus on endocrine disrupting properties and cumulative risk assessment, The Netherlands Food and Consumer Product Safety Authority (NVWA), National Institute for Public Health and the Environment, RIVM Report 2018-0161, Bilthoven (The Netherlands) 2018; https://www.rivm.nl/bibliotheek/rapporten/2018-0161.pdf; last access date October 30, 2019.
- 17. W. Brand, P. E. Boon, E. V. S. Hessel, J. A. J. Meesters, M. Weda and A. G. Schuur, Exposure to and toxicity of methyl-, ethyl- and propylparaben – A literature review with a focus on endocrine-disrupting properties, RIVM Report 2017-0028, The Netherlands Food and Consumer Product Safety Authority (NVWA), National Institute for Public Health and the Environment, RIVM Report 2018-0161, Bilthoven (The Netherlands) 2018; https://www.rivm.nl/bibliotheek/rapporten/2017-0028.pdf; last access date October 30, 2019.
- 18. European Commision (EC), Scientific Committee on Consumer Safety (SCCS), Opinion on Parabens. Updated Request for a Scientific Opinion on Propyl- and Butylparaben; SCCS/1514/13, SCCS, Luxembourg, May 3, 2013; https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_132.pdf; last access date October 29, 2019.
- 19. N. R. Janjua, H. Fredericksen, N. E. Skakkebaek, H. C. Wulf and A. M. Andersson, Urinary excretion of phthalates and paraben after repeated whole-body topical application in humans, Int. J. Androl.31 (2008) 118–130; https://doi.org/10.1111/j.1365-2605.2007.00841.x
- 20. R. T. Engeli, S. R. Rohrer, A. Vuorinen, S. Herdlinger, T. Kaserer, S. Leugger, D. Schuster and A. Oder-matt, Interference of paraben compounds with estrogen metabolism by inhibition of 17β-hydroxysteroid dehydrogenases, Int. J. Mol. Sci. 18 (2017) 1–13; https://doi.org/10.3390/ijms18092007
- 21. M. Y. Shin, C. Shin, J. W. Choi, J. Lee, S. Lee and S. Kim, Pharmacokinetic profile of propyl paraben in humans after oral administration, Environ. Int.130 (2019) Article ID 104917 (9 pages); https://doi.org/10.1016/j.envint.2019.104917
- 22. M. G. Soni, S. L. Taylor, N. A. Greenberg and G. A. Burdock, Evaluation of the health aspects of methyl paraben: a review of the published literature, Food Chem. Toxicol.40 (2002) 1335–1373; https://doi.org/10.1016/S0278-6915(02)00107-2
- 23. M. Lakeram, A. J. Paine, D. J. Lockley, D. J. Sanders, R. Pendlington and B. Forbes, Transesterification of p-hydroxybenzoate esters (parabens) by human intestinal (Caco-2) cells, Xenobiotica36 (2006) 739–749; https://doi.org/10.1080/00498250600738637
- 24. H. M. Harville, R. Voorman and J. J. Prusakiewicz, Comparison of paraben stability in human and rat skin, Drug Metab. Lett.1 (2007) 17–21, https://doi.org/10.2174/187231207779814300
- 25. W. L. Ma, X. Zhao, Z. Y. Lin, M. O. Mohammed, Z. F. Zhang, L. Y. Liu, W. W. Song and Y. F. Li, A survey of parabens in commercial pharmaceuticals from China and its implications for human exposure, Environ. Int.95 (2016) 30–35; https://doi.org/10.1016/j.envint.2016.07.013
- 26. S. M. Bell, X. Chang, J. F. Wambaugh, D. G. Allen, M. Bartels, K. L. R. Brouwer, W. M. Casey, N. Choksi, S. S. Ferguson, G. Fraczkiewicz, A. M. Jarabek, A. Ke, A. Lumen, S. G. Lynn, A. Paini, P. S. Price, C. Ring, T. W. Simon, N. S. Sipes, C. S. Sprankle, J. Strickland, J. Troutman, B. A. Wetmore and N. C. Kleinstreuer, In vitro to in vivo extrapolation for high throughput prioritization and decision making, Toxicol. In Vitro47 (2018) 213–227; https://doi.org/10.1016/j.tiv.2017.11.016
- 27. A. Kizhedath, S. Wilkinson and J. Glassey, Assessment of hepatotoxicity and dermal toxicity of butyl paraben and methyl paraben using HepG2 and HDFn in vitro models, Toxicol. In Vitro55 (2019) 108–115; https://doi.org/10.1016/j.tiv.2018.12.007
- 28. M. Calafat, X. Ye, L. Y. Wong, A. M. Bishop and L. L. Needham, Urinary concentrations of four parabens in the U.S. population, Environ. Health Perspect. 118 (2010) 679–685; https://doi.org/10.1289/ehp.0901560
- 29. R. S. Tade, M. P. More, V. K. Chatap, P. K. Deshmukh and P. O. Patil, Safety and toxicity of parabens in pharmaceutical and food products, Inventi Rapid Pharm. Pract. No. 3 (2018) 1–9.
- 30. F. Artacho-Cordón, J. P. Arrebola, O. Nielsen, P. Hernández, N. E. Skakkebaek, M. F. Fernández, A. M. Andersson, N. Olea and H. Frederiksen, Assumed nonpersistent environmental chemicals in human adipose tissue; matrix stability and correlation with levels measured in urine and serum, Environ. Res.156 (2017) 120–127; https://doi.org/10.1016/j.envres.2017.03.030
- 31. P. M. Ashrap, D. J. Watkins, A. M. Calafat, X. Ye, Z. Rasario, F. Brown, C. M. Vélez-Vegae, A. Alshawabkeh, J. F. Corfero and J. D. Meeker, Elevated concentrations of urinary triclocarban, phenol and paraben among pregnant women in Northern Puerto Rico: predictors and trends, Environ. Int.121 (2018) 990–1002; https://doi.org/10.1016/j.envint.2018.08.020
- 32. H. Frederiksen, N. Jørgensen and A. M. Andersson, Parabens in urine, serum and seminal plasma from healthy Danish men determined by liquid chromatography–tandem mass spectrometry (LC– MS/MS), J. Expo. Sci. Env. Epid.21 (2011) 262–271; https://doi.org/10.1038/jes.2010.6
- 33. B. F. Pycke, L. A. Geer, M. Dalloul, O. Abulafia and R. U. Halden, Maternal and fetal exposure to parabens in a multiethnic urban US population, Environ. Int.84 (2015) 193–200; https://doi.org/10.1016/j.envint.2015.08.012
- 34. C. V. Towers, P. D. Terry, D. Lewis, B. Howard, W. Chambers, C. Armistead, B. Weitz, S. Porter, C. J. Borman, R. C. M. Kennedy and J. Chen, Transplacental passage of antimicrobial paraben preservatives, J. Expo. Sci. Env. Epid. 25 (2015) 604–607; https://doi.org/10.1038/jes.2015.27
- 35. E. J. Routledge, J. Parker, J. Odum, J. Ashby and J. P. Sumpter, Some alkyl hydroxy benzoate preservatives (parabens) are estrogenic, Toxicol. Appl. Pharmacol.153 (1998) 12–19; https://doi.org/10.1006/taap.1998.8544
- 36. J. R. Byford, L. E. Shaw, M. G. B. Drew, G. S. Pope, M. J. Sauer and P. D. Darbre, Oestrogenic activity of parabens in MCF7 human breast cancer cells, J. Steroid Biochem. Mol. Biol. 80 (2002) 49–60; https://doi.org/10.1016/S0960-0760(01)00174-1
- 37. R. Golden, J. Gandy and G. Vollmer, A review of the endocrine activity of parabens and implications for potential risks to human health, Crit. Rev. Toxicol. 35 (2005) 435–458; https://doi.org/10.1080/10408440490920104
- 38. A. F. Fransway, P. J. Fransway, D. V. Belsito and J. A. Yiannias, Paraben toxicology, Dermatitis30 (2019) 32–45; https://doi.org/10.1097/DER.0000000000000428
- 39. J. A. van Meeuwen, O. van Son, A. H. Piersma, P. C. de Jong and M. van den Berg, Aromatase inhibiting and combined estrogenic effects of parabens and estrogenic effects of other additives in cosmetics, Toxicol. Appl. Pharmacol. 230 (2008) 372–382; https://doi.org/10.1016/j.taap.2008.03.002
- 40. R. J. Witorsch and J. A. Thomas, Personal care products and endocrine disruption: A critical review of the literature, Crit. Rev. Toxicol.40 (2010) 1–30; https://doi.org/10.3109/10408444.2010.515563
- 41. A. M. Wróbel and E. Ł. Gregoraszczuk, Actions of methyl-, propyl- and butylparaben on estrogen receptor-α and -β and the progesterone receptor in MCF-7 cancer cells and non-cancerous MCF-10A cells, Toxicol. Lett.230 (2014) 375–381; https://doi.org/10.1016/j.toxlet.2014.08.012
- 42. J. H. Lee, M. Lee, C. Ahn, H. Y. Kang, D. N. Tran and E. B. Jeung, Parabens accelerate ovarian dys-function in a 4-vinylcyclohexene diepoxide-induced ovarian failure model, Int. J. Environ. Res. Public Health14 (2017) Article ID 161 (13 pages); https://doi.org/10.3390/ijerph14020161
- 43. Y. Nishihama, J. Yoshinaga, A. Iida, S. Konishi, H. Imai, M. Yoneyama, D. Nakajima and H. Shiraishi, Association between paraben exposure and menstrual cycle in female university students in Japan, Reprod. Toxicol.63 (2016) 107–113; https://doi.org/10.1016/j.reprotox.2016.05.010
- 44. S. Oishi, Effects of butyl paraben on the male reproductive system in mice, Arch. Toxicol.76 (2002) 423–429; https://doi.org/10.1007/s00204-002-0360-8
- 45. S. Oishi, Effects of propylparaben on the male reproductive system, Food Chem. Toxicol. 40 (2002) 1807–1813; https://doi.org/10.1016/S0278-6915(02)00204-1
- 46. A. M. Hoberman, D. K. Schreur, T. Leazer, G. P. Daston, P. Carthew, T. Re, L. Loretz and P. Mann, Lack of effect of butylparaben and methylparaben on the reproductive system in male rats, Birth Defects Res. B Dev. Reprod. Toxicol.83 (2008) 123–133; https://doi.org/10.1002/bdrb.20153
- 47. S. Khanna, P. R. Dash and P. D. Darbre, Exposure to parabens at the concentration of maximal proliferative response increases migratory and invasive activity of human breast cancer cells in vitro, J. Appl. Toxicol. 34 (2014) 1051–1059; https://doi.org/10.1002/jat.3003
- 48. P. D. Darbre, Endocrine disruptors and obesity, Curr. Obes. Rep.6 (2017) 18–27; https://doi.org/10.1007/s13679-017-0240-4
- 49. D. G. Bayülken, B. A. Tüylü, H. Sinan and H. Sivaset, Investigation of genotoxic effects of paraben in cultured human lymphocytes, Drug Chem. Toxicol. 42 (2019) 349–356; https://doi.org/10.1080/01480545.2017.1414834
- 50. D. G. Bayülken and B. A. Tüylü, In vitro genotoxic and cytotoxic effects of some paraben esters on human peripheral lymphocytes, Drug Chem. Toxicol. 42 (2019) 386–393; https://doi.org/10.1080/01480545.2018.1457049
- 51. M. M. Smarr, M. Honda, K. Kannan, Z. Chen, S. Kim and G. M. B. Louis, Male urinary biomarkers of antimicrobial exposure and bi-directional associations with semen quality parameters, Reprod. Toxicol. 77 (2018) 103–108; https://doi.org/10.1016/j.reprotox.2018.02.008
- 52. M. M. Smarr, R. Sundaram, M. Honda, K. Kannan and G. M. B. Louis, Urinary concentrations of parabens and other antimicrobial chemicals and their association with couples’ fecundity, Environ. Health Perspect. 125 (2017) 730–736; https://doi.org/10.1289/EHP189
- 53. L. Mínguez-Alarcón, Y.-H. Chiu, C. Messerlian, P. L. Williams, M. E. Sabatini, T. L. Toth, J. B. Ford, A. M. Calafat and R. Hauser – EARTH Study Team, Urinary paraben concentrations and in vitro fertilization outcomes among women from a fertility clinic, Fertil. Steril. 105 (2016) 714–721; https://doi.org/10.1016/j.fertnstert.2015.11.021
- 54. The European Medicinal Agency (EMA), The Committee for Medicinal Products for Human Use and The Safety Working Party (SWP), Reflection Paper on the Use of Methyl- and Propylparaben as Excipients in Human Medicinal Products for Oral Use, London, October 2015; https://www.ema.europa.eu/en/documents/scientific-guideline/reflection-paper-use-methyl-propylparaben-excipients-human-medicinal-products-oral-use_en.pdf; last access date October 30, 2019.
- 55. L. E. Dodge, K. E. Kelley, P. L. Williams, M. A. Williams, S. Hernandez-Diaz, S. A. Missmer and R. Hauser, Medications as a source of paraben exposure, Reprod. Toxicol. 52 (2015) 93–100; https://doi.org/10.1016/j.reprotox.2015.02.002
- 56. Centers for Disease Control and Prevention, National Center for Environmental Health, Division of Laboratory Sciences, Fourth National Report on Human Exposure to Environmental Chemicals, CDC, Atlanta (GA), January 2019; https://www.cdc.gov/exposurereport/pdf/FourthReport_UpdatedTables_Volume1_Jan2019-508.pdf; last access date March 5, 2020.
- 57. L. E. Dodge, J. W. Choi, K. E. Kelley, S. Herńandez-Diaz and R. Hauser, Medications as a potential source of exposure to parabens in the U.S. population, Environ. Res. 164 (2018) 580–584, https://doi.org/10.1016/j.envres.2018.03.035
- 58. A. Pop, T. Drugan, A. C. Gutleb, D. Lupu, J. Cherfan J, F. Loghin and B. Kiss, Estrogenic and anti-estrogenic activity of butylparaben, butylated hydroxyanisole, butylated hydroxytoluene and propyl gallate and their binary mixtures on two estrogen responsive cell lines (T47D-Kbluc, MCF-7), J. Appl. Toxicol.38 (2018) 944–957; https://doi.org/10.1002/jat.3601
- 59. The European Parliament and the Council of the European Union, Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products (Text with EEA relevance), OJ L 342 (2009) 59-209, November 2009; https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32009R1223&from=EN; last access date December 20, 2019
- 60. The European Parliament and the Council of the European Union, Regulation (EC) No 1333/2008 of the European Parliament and of the Council of 16 December 2008 on food additives (Text with EEA relevance), OJ L 354 (2008) 16–33, December 2008; https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32008R1333&from=EN; last access date December 20, 2019.
- 61. The European Parliament and the Council of the European Union, Regulation (EC) No 648/2004 of the European Parliament and of the Council of 31 March 2004 on detergents (Text with EEA relevance) OJ L 104 (2004) 1–35, March 2004; https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32004R0648; last access date December 20, 2019.
- 62. European Commission, Report from The European Commission to The European Parliament and the Council, Review of Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products with regard to substances with endocrine-disrupting properties, November 2018; https://www.europarl.europa.eu/RegData/docs_autres_institutions/commission_europeenne/com/2018/0739/COM_COM(2018)0739_EN.pdf; last access date October 9, 2019.
- 63. The European Food Safety Authority (EFSA), Opinion of the scientific panel on food additives, flavourings, processing aids and materials in contact with food on a request from the commission related to para hydroxybenzoates (E 214-219), Question number EFSA-Q-2004-063 (adopted on 13 July 2004), EFSA J. 83 (2004) 1–26; https://efsa.onlinelibrary.wiley.com/doi/epdf/10.2903/j.efsa.2004.83
- 64. L. Cuzzolin, Neonates exposed to excipients: concern about safety, J. Pediatr. Neonat. Individual Med. 7 (2018) e070112 (10 pages); https://doi.org/10.7363/070112
- 65. The European Commission (EC), Scientific Committee on Consumer Safety (SCCS), Clarification on opinion SCCS/1348/10 in the light of the Danish clause of safeguard banning the use of parabens in cosmetic products intended for children under three years of age, SCCS, Luxembourg, October 2011; https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_069.pdf; last access date December 20, 2019.
- 66. K. S. Valeur, H. Holst and K. Allegaert, Excipients in neonatal medicinal products: Never prescribed, commonly administered, Pharm. Med. 32 (2018) 251–258; https://doi.org/10.1007/s40290-018-0243-9
- 67. S. Kang, S. Kim, J. Park, H. J. Kim, J. Lee, G. Choi, S. Choi, S. Kim, S. Y. Kim, H. B. Moon, S. Kim, Y. L. Kho and K. Choi, Urinary paraben concentrations among pregnant women and their matching newborn infants of Korea, and the association with oxidative stress biomarkers, Sci. Total Environ. 461–462 (2013) 214–221, https://doi.org/10.1016/j.scitotenv.2013.04.097
- 68. N.-Y. Park, Y. H. Cho, K. Choi, E.-H. Lee, Y. J. Kim, J. H. Kim and Y. Kho, Parabens in breast milk and possible sources of exposure among lactating women in Korea, Environ. Poll. 255 (2019) Article ID 113142; https://doi.org/10.1016/j.envpol.2019.113142
- 69. S. Yakkundi, H. Mulla, H. Pandya, M. A. Turner and J. McElnay, Quantitative analysis of methyl and propyl parabens in neonatal DBS using LC-MS/MS, Bioanalysis8 (2016) 1173–1182; https://doi.org/10.4155/bio-2016-0029
- 70. M. A. Turner, J. C. Duncan, U. Shah, T. Metsvaht, H. Varendi, G. Nellis, I. Lutsar, S. Yakkundi, J. C. McElnay, H. Jandya, H. Mulla, P. Vaconsin, T. Storme, A. Rieutord and A. J. Nunn, Risk assessment of neonatal excipient exposure: lessons from food safety and other areas, Adv. Drug Deliv. Rev.73 (2014) 89–101; https://doi.org/10.1016/j.addr.2013.11.003
- 71. M. Bilal and H. M. N. Iqbal, An insight into toxicity and human-health-related adverse consequences of cosmeceuticals – A review, Sci. Total Environ.670 (2019) 555–568; https://doi.org/10.1016/j.scitotenv.2019.03.261
- 72. C. L. Burnett, I. Boyer, W. F. Bergfeld, D. V. Belsito, R. A. Hill, C. D. Klaassen, D. C. Liebler, J. G. Marks, Jr., R. C. Shank, T. J. Slaga, P. W. Snyder, L. J. Gill and B. Heldreth, Amended safety assessment of methylisothiazolinone as used in cosmetics, Int. J. Toxicol. 38 (2019) 70–84; https://doi.org/10.1177/1091581819838792
- 73. J. D. Lee, J. Y. Lee, S. J. Kwack, C. Y. Shin, H. J. Jang, H. Y. Kim, M. K. Kim, D. W. Seo, B. M. Lee and K. B. Kim, Risk assessment of triclosan, a cosmetic preservative, Toxicol. Res.35 (2019) 137–154; https://doi.org/10.5487/TR.2019.35.2.137
- 74. The SUBSPORTplus Portal, SUBSPORT project, SUBSPORT Specific Substances Alternatives Assessment – Parabens, March 2013; http://www.subsportplus.eu/wp-content/uploads/data/parabens.pdf; last access date December 20, 2019.
- 75. M. Eisenhut, The toxicity of essential oils, Int. J. Infect. Dis. 11 (2007) 365; https://doi.org/10.1016/j.ijid.2006.07.004
- 76. Council of Europe, European Directorate for the Quality of Medicines & HealthCare (EDQM), Guidance on essential oils in cosmetic products, 2016; https://zdravlje.gov.hr/UserDocsImages/2017%20dokumenti%20razni/Guidance%20on%20essential%20oils%20in%20cosmetic%20products_EDQM%202016.PDF; last access date December 22, 2019